Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Immunomedics Inc (NASDAQ:IMMU)

4.33
Delayed Data
As of Jan 20
 -0.13 / -2.91%
Today’s Change
1.61
Today|||52-Week Range
5.44
+17.98%
Year-to-Date

Today’s Trading

Previous close4.46
Today’s open4.51
Day’s range4.17 - 4.55
Volume4,385,750
Average volume (3 months)1,923,970
Market cap$458.7M
Dividend yield--
Data as of 4:00pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)-21.57%
Earnings growth (this year)+17.74%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)-42.81%
P/E ratioNM
Price/Sales68.00
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CLDXCelldex Therapeutics...+0.07+2.10%
ALRPRBAlere Inc-2.50-0.76%
LNTHLantheus Holdings In...+0.10+1.10%
--Quidel Corp-0.28-1.54%
Data as of 4:00pm ET, 01/20/2017

Financials

Next reporting dateFebruary 8, 2017
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$3.2M
Annual profit (last year)-$59.0M
Net profit margin-1,825.93%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Scientific &
Patent Officer
David M. Goldenberg
President, Chief Executive Officer &
Director
Cynthia L. Sullivan
Corporate headquarters
Morris Plains, New Jersey

Forecasts


Search for Jobs